2018-3-2 Archives - International Journal of Molecular and Immuno Oncology

Year: 2018, Volume: 3, Issue: 2, July-September

Editorial

Nanobyte

Radhika A. Vaishnav

DOI: 10.18203/issn.2456-3994.IntJMolImmunoOncol20183224

PDF

p.36-36

Original Article

Role of pretreatment neutrophil-to-lymphocyte ratio as an independent prognostic factor in oral squamous cell carcinoma patients: A prospective study in a tertiary care center

Shashwat Tiwari, Shivani Nautiyal

DOI: 10.18203/issn.2456-3994.IntJMolImmunoOncol20183225

PDF

p.37-40

Original Article

Benefits of the early detection of M351T mutation, by allele-specific oligonucleotide polymerase chain reaction, in imatinib-resistant chronic myelogenous leukemia (CML) – A retrospective analysis

Mukul A. Gharote, Harsha P. Panchal, Rakesh Rawal, Krupa Shah, Asha Anand, Apurva P. Patel, Sonia K. Parikh

DOI: 10.18203/issn.2456-3994.IntJMolImmunoOncol20183226

PDF

p.41-42

Review Article

Cancer immunotherapy

Akhil Jain, Sajjan Rajpurohit

DOI: 10.18203/issn.2456-3994.IntJMolImmunoOncol20183227

PDF

p.45-53

Review Article

Immune profile of tumor and chemotherapy

Bakulesh Khamar

DOI: 10.18203/issn.2456-3994.IntJMolImmunoOncol20183228

PDF

p.54-63

Brief Commentary

Polybromo-1 loss in cholangiocarcinoma development: Expressional analysis

Sora Yasri, Viroj Wiwanitkit

DOI: 10.18203/issn.2456-3994.IntJMolImmunoOncol20183229

PDF

p.64-64

Brief Commentary

Extreme leukocytosis in a healthy young man and use of polymerase chain reaction for detection of BCR‑ABL

Beuy Joob, Viroj Wiwanitkit

DOI: 10.18203/issn.2456-3994.IntJMolImmunoOncol20183230

PDF

p.65-65

Brief Commentary

Complex three-way Philadelphia translocation t(6;9;22) (p23;q34;q11.2) along with unusual t(1;4): A chronic myeloid leukemia case report

M. Kumar, Bekleshwar Salona, Shiv Murti Kumar, Akshay Gore, Shivani Sharma

DOI: 10.18203/issn.2456-3994.IntJMolImmunoOncol20183231

PDF

p.66-66

© Copyright 2024 – International Journal of Molecular and Immuno Oncology – All rights reserved.
Published by Scientific Scholar on behalf of Molecular Oncology Society and Immuno Oncology Leadership Network.

ISSN (Online): 2456-3994
ISSN (Print): 2836-3779